Developing neural stem cell-based treatments for neurodegenerative diseases.

about

Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.

P2860

Q26799331-5312E54E-C46F-4782-AE58-261A63B6B12E Q38712304-3D1674CD-0463-4832-9559-349C3731184D

P2860

Developing neural stem cell-based treatments for neurodegenerative diseases.

Item

http://www.wikidata.org/entity/Q41547468

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Developing neural stem cell-based treatments for neurodegenerative diseases.

@en

type

Item

label

Developing neural stem cell-based treatments for neurodegenerative diseases.

@en

prefLabel

Developing neural stem cell-based treatments for neurodegenerative diseases.

@en

P1476

Developing neural stem cell-based treatments for neurodegenerative diseases.

@en

P2093

James A Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status

Alzheimer Disease in the US Population

Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models

Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion

Demography. Broken limits to life expectancy.

Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate.

Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats.

Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease.

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

P2888

scrt461

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/SCRT461

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James A Byrne

P577

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265056207

http://www.w3.org/2001/XMLSchema#string

P6179

1016660078

http://www.w3.org/2001/XMLSchema#string

P698

25157920

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

4076634

http://www.w3.org/2001/XMLSchema#string

Developing neural stem cell-based treatments for neurodegenerative diseases.

about

P2860

P2860

Developing neural stem cell-based treatments for neurodegenerative diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P932